<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Cresci, Gail A.</style></author><author><style face="normal" font="default" size="100%">Teitelbaum, Daniel H.</style></author><author><style face="normal" font="default" size="100%">Sadowsky, Michael J.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Role of Gut Dysbiosis and Its Treatment in the Critically Ill</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-17</style></pages><abstract><style  face="normal" font="default" size="100%">Altered intestinal microbiota in critically ill patients leads to increased pathogens and infections, which may be improved with synbiotic therapy. Stress, antibiotics, and parenteral therapy have been linked to gut dysbiosis. Fecal microbiota transplantation is a promising treatment for Clostridium difficile infection and may work by altering bile acid composition.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>